My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 168

    1.

    In vitro-deranged intestinal immune response to gliadin in type 1 diabetes.

    Auricchio R, Paparo F, Maglio M, Franzese A, Lombardi F, Valerio G, Nardone G, Percopo S, Greco L, Troncone R.

    Diabetes. 2004 Jul;53(7):1680-3.PMID: 15220190 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.

    Mazzarella G, Maglio M, Paparo F, Nardone G, Stefanile R, Greco L, van de Wal Y, Kooy Y, Koning F, Auricchio S, Troncone R.

    Gut. 2003 Jan;52(1):57-62.PMID: 12477760 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Gluten sensitivity in a subset of children with insulin dependent diabetes mellitus.

    Troncone R, Franzese A, Mazzarella G, Paparo F, Auricchio R, Coto I, Mayer M, Greco L.

    Am J Gastroenterol. 2003 Mar;98(3):590-5.PMID: 12650792 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa.

    Paparo F, Petrone E, Tosco A, Maglio M, Borrelli M, Salvati VM, Miele E, Greco L, Auricchio S, Troncone R.

    Am J Gastroenterol. 2005 Oct;100(10):2294-8.PMID: 16181383 [PubMed - indexed for MEDLINE]Related articles

    5.

    Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

    Salvati VM, Mazzarella G, Gianfrani C, Levings MK, Stefanile R, De Giulio B, Iaquinto G, Giardullo N, Auricchio S, Roncarolo MG, Troncone R.

    Gut. 2005 Jan;54(1):46-53.PMID: 15591503 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.

    Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.

    BMC Immunol. 2008 Feb 29;9:6.PMID: 18312620 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.

    Mazzarella G, Stefanile R, Camarca A, Giliberti P, Cosentini E, Marano C, Iaquinto G, Giardullo N, Auricchio S, Sette A, Troncone R, Gianfrani C.

    Gastroenterology. 2008 Apr;134(4):1017-27. Epub 2008 Jan 11.PMID: 18395083 [PubMed - indexed for MEDLINE]Related articles

    8.

    Gluten stimulation of coeliac mucosa in vitro induces activation (CD25) of lamina propria CD4+ T cells and macrophages but no crypt-cell hyperplasia.

    Halstensen TS, Scott H, Fausa O, Brandtzaeg P.

    Scand J Immunol. 1993 Dec;38(6):581-90.PMID: 7902998 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.

    Fais S, Maiuri L, Pallone F, De Vincenzi M, De Ritis G, Troncone R, Auricchio S.

    Gut. 1992 Apr;33(4):472-5.PMID: 1582589 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.

    Pizzuti D, Buda A, D'Odorico A, D'Incà R, Chiarelli S, Curioni A, Martines D.

    Scand J Gastroenterol. 2006 Nov;41(11):1305-11.PMID: 17060124 [PubMed - indexed for MEDLINE]Related articles

    11.

    Markers of potential coeliac disease in patients with Hashimoto's thyroiditis.

    Valentino R, Savastano S, Maglio M, Paparo F, Ferrara F, Dorato M, Lombardi G, Troncone R.

    Eur J Endocrinol. 2002 Apr;146(4):479-83.PMID: 11916614 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes.

    Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E.

    Diabetes. 2003 Sep;52(9):2287-95.PMID: 12941768 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture.

    Falchuk ZM, Gebhard RL, Sessoms C, Strober W.

    J Clin Invest. 1974 Feb;53(2):487-500.PMID: 11344562 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells.

    Gianfrani C, Levings MK, Sartirana C, Mazzarella G, Barba G, Zanzi D, Camarca A, Iaquinto G, Giardullo N, Auricchio S, Troncone R, Roncarolo MG.

    J Immunol. 2006 Sep 15;177(6):4178-86.PMID: 16951383 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease.

    Lähteenoja H, Mäki M, Viander M, Räihä I, Vilja P, Rantala I, Toivanen A, Syrjänen S.

    Am J Gastroenterol. 2000 Oct;95(10):2880-7.PMID: 11051363 [PubMed - indexed for MEDLINE]Related articles

    16.

    Gliadin activates mucosal cell mediated immunity in cultured rectal mucosa from coeliac patients and a subset of their siblings.

    Troncone R, Mazzarella G, Leone N, Mayer M, De Vincenzi M, Greco L, Auricchio S.

    Gut. 1998 Oct;43(4):484-9.PMID: 9824574 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients.

    Maiuri L, Picarelli A, Boirivant M, Coletta S, Mazzilli MC, De Vincenzi M, Londei M, Auricchio S.

    Gastroenterology. 1996 May;110(5):1368-78.PMID: 8613040 [PubMed - indexed for MEDLINE]Related articles

    18.

    Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.

    Martucci S, Fraser JS, Biagi F, Corazza GR, Ciclitira PJ, Ellis HJ.

    Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1293-8.PMID: 14624152 [PubMed - indexed for MEDLINE]Related articles

    19.

    Secretion of gliadin antibody by coeliac jejunal mucosal biopsies cultured in vitro.

    Ciclitira PJ, Ellis HJ, Wood GM, Howdle PD, Losowsky MS.

    Clin Exp Immunol. 1986 Apr;64(1):119-24.PMID: 3731523 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.

    Molberg O, Kett K, Scott H, Thorsby E, Sollid LM, Lundin KE.

    Scand J Immunol. 1997 Sep;46(3):103-9.PMID: 9315123 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity